πŸ‡ΊπŸ‡Έ FDA
Patent

US 7732441

Azabicycloalkane compounds

granted A61KA61K31/46A61K31/4743

Quick answer

US patent 7732441 (Azabicycloalkane compounds) held by Theravance, Inc. expires Mon Jun 03 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Theravance, Inc.
Grant date
Tue Jun 08 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 03 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61K, A61K31/46, A61K31/4743, A61P, A61P1/04